Literature DB >> 16821026

Coronary artery calcifications in children with end-stage renal disease.

Mahmut Civilibal1, Salim Caliskan, Ibrahim Adaletli, Huseyin Oflaz, Lale Sever, Cengiz Candan, Nur Canpolat, Ozgur Kasapcopur, Sebuh Kuruoglu, Nil Arisoy.   

Abstract

Coronary artery calcification (CAC) is common in adults with end-stage renal disease (ESRD), but little is known about the prevalence and the extent of it in children. We used multidetector spiral computed tomography (MDCT), echocardiography, and carotid and brachial high-resolution ultrasonography to screen for the presence and predisposing factors of CAC in 53 children with ESRD [15 hemodialysis (HD) patients, 24 peritoneal dialysis (PD) patients, and 14 renal transplant (rTx) recipients]. CAC was present in 15% of patients (three HD patients, three PD patients, and two rTx). The mean age of the patients with CAC was 16.4 years (range: 11.0-21.2 years), and their median CAC score was 101.3, ranging from 8.5 to 4,322 according to the Agatston method. The patients with CAC had longer duration of total dialysis (P=0.005), had higher time-integrated serum phosphorus (P<0.001), calcium-phosphate (CaxP) product (P=0.012), intact parathyroid hormone (P=0.010), vitamin B(12) levels (P=0.010), the amount of cumulative calcium-containing oral phosphate binders (OBPs) (P<0.001), and calcitriol intake (P<0.001), and had lower serum hemoglobin level (P=0.014). Interventricular septum systolic thickness (P=0.033) was significantly higher, relative wall thickness (P=0.062) tended to be higher, and flow-mediated endothelium-dependent dilatations (P=0.071) were lower without reaching statistically significant levels in those with CAC. A stepwise logistic regression analysis revealed that serum phosphorus (P=0.018) and the cumulative exposure to calcium-containing OPBs (P=0.016) were the most significant independent predictors in the development of CAC. These results indicate that even adolescents and children with ESRD may have coronary calcifications. We concluded that impaired divalent ion metabolism is the main factor in the formation of CAC in this age group.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16821026     DOI: 10.1007/s00467-006-0159-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  37 in total

1.  Quantification of coronary artery calcium using ultrafast computed tomography.

Authors:  A S Agatston; W R Janowitz; F J Hildner; N R Zusmer; M Viamonte; R Detrano
Journal:  J Am Coll Cardiol       Date:  1990-03-15       Impact factor: 24.094

2.  Excerpts from the United States Renal Data System 1998 Annual Data Report.

Authors: 
Journal:  Am J Kidney Dis       Date:  1998-08       Impact factor: 8.860

3.  Early evidence of endothelial vasodilator dysfunction at coronary branch points.

Authors:  J M McLenachan; J Vita; D R Fish; C B Treasure; D A Cox; P Ganz; A P Selwyn
Journal:  Circulation       Date:  1990-10       Impact factor: 29.690

4.  Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors.

Authors:  M M Mitsnefes; S R Daniels; S M Schwartz; R A Meyer; P Khoury; C F Strife
Journal:  Pediatr Nephrol       Date:  2000-09       Impact factor: 3.714

5.  Hyperhomocyst(e)inaemia in children with chronic renal failure.

Authors:  M Lilien; M Duran; K Van Hoeck; B T Poll-The; C Schröder
Journal:  Nephrol Dial Transplant       Date:  1999-02       Impact factor: 5.992

6.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.

Authors:  D S Celermajer; K E Sorensen; V M Gooch; D J Spiegelhalter; O I Miller; I D Sullivan; J K Lloyd; J E Deanfield
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

Review 7.  Slowing the progression of vascular calcification in hemodialysis.

Authors:  Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2003-09       Impact factor: 10.121

8.  Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk.

Authors:  G de Simone; R B Devereux; S R Daniels; M J Koren; R A Meyer; J H Laragh
Journal:  J Am Coll Cardiol       Date:  1995-04       Impact factor: 24.094

9.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

Authors:  G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

10.  Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis.

Authors:  Mitsuteru Matsuoka; Kunitoshi Iseki; Masahiro Tamashiro; Naoko Fujimoto; Nobuyoshi Higa; Takashi Touma; Shuichi Takishita
Journal:  Clin Exp Nephrol       Date:  2004-03       Impact factor: 2.801

View more
  50 in total

1.  Can dialysis modality influence cardiovascular outcome?

Authors:  Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2012-06-03       Impact factor: 3.714

2.  Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease.

Authors:  Manish D Sinha; Charles Turner; Caroline J Booth; Simon Waller; Pernille Rasmussen; David J A Goldsmith; John M Simpson
Journal:  Pediatr Nephrol       Date:  2015-05-15       Impact factor: 3.714

Review 3.  Cardiovascular disease in children with chronic kidney disease.

Authors:  Mark M Mitsnefes
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

4.  Glucose intolerance: is it a risk factor for cardiovascular disease in children with chronic kidney disease?

Authors:  Nur Canpolat; Salim Caliskan; Lale Sever; Alper Guzeltas; Fatih Kantarci; Cengiz Candan; Mahmut Civilibal; Ozgur Kasapcopur; Nil Arisoy
Journal:  Pediatr Nephrol       Date:  2011-10-08       Impact factor: 3.714

5.  Vitamin D and osteogenic differentiation in the artery wall.

Authors:  Jeffrey J Hsu; Yin Tintut; Linda L Demer
Journal:  Clin J Am Soc Nephrol       Date:  2008-06-18       Impact factor: 8.237

6.  Progression of coronary calcification in pediatric chronic kidney disease stage 5.

Authors:  Mahmut Civilibal; Salim Caliskan; Sebuh Kurugoglu; Cengiz Candan; Nur Canpolat; Lale Sever; Ozgur Kasapcopur; Nil Arisoy
Journal:  Pediatr Nephrol       Date:  2008-11-04       Impact factor: 3.714

7.  Circulating calcification inhibitors and vascular properties in children after renal transplantation.

Authors:  Marieke J H van Summeren; Jeroen M Hameleers; Leon J Schurgers; Arnold P G Hoeks; Cuno S P M Uiterwaal; Thilo Krüger; Cees Vermeer; Wietse Kuis; Marc R Lilien
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

Review 8.  Long-term outcome of chronic dialysis in children.

Authors:  Rukshana Shroff; Sarah Ledermann
Journal:  Pediatr Nephrol       Date:  2008-01-23       Impact factor: 3.714

9.  What parathyroid hormone levels should we aim for in children with stage 5 chronic kidney disease; what is the evidence?

Authors:  Lesley Rees
Journal:  Pediatr Nephrol       Date:  2007-11-28       Impact factor: 3.714

10.  Vascular calcifications, vertebral fractures and mortality in haemodialysis patients.

Authors:  Minerva Rodríguez-García; Carlos Gómez-Alonso; Manuel Naves-Díaz; Jose Bernardino Diaz-Lopez; Carmen Diaz-Corte; Jorge B Cannata-Andía
Journal:  Nephrol Dial Transplant       Date:  2008-08-25       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.